| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.07 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.071 | 0.07 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.093 | 0.07 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.07 |